Author name: Zach Galati

Key Congressional Committee Recommends New Federal Research in SMA

A key congressional committee approved fiscal year 2026 legislation that now prioritizes new federal research funding for spinal muscular atrophy (SMA). The U.S. Senate Appropriations Committee recognized the unmet medical needs of individuals with SMA, including those from military and veteran families, by this year adding “spinal muscular atrophy” within a biomedical research program managed […]

Key Congressional Committee Recommends New Federal Research in SMA Read More »

This August is Spinal Muscular Atrophy (SMA) Awareness Month! 

Whether you live with SMA, know someone who does, work in research or care, or are beginning your journey with the community—SMA Awareness Month is a time to come together to celebrate progress, honor experiences, reflect on challenges, and build momentum for the future. The theme of SMA awareness month, “Breakthroughs Begin with You,” puts

This August is Spinal Muscular Atrophy (SMA) Awareness Month!  Read More »

Thank You for an Amazing 2025 Annual SMA Conference!

Thank you to everyone who attended the 2025 Annual SMA Conference at the Disneyland Hotel in Anaheim, California! It was an impactful weekend of opportunities to connect, learn, and have fun. We’re thrilled to share that nearly 2,800 attendees joined us – our second-largest conference to date! It was an honor to have individuals with

Thank You for an Amazing 2025 Annual SMA Conference! Read More »

The Future of Accessible Air Travel and Current Challenges for the SMA Community at Cure SMA’s 2025 Annual Conference

At this year’s Annual Cure SMA Conference in Anaheim, California, more than 2,800 attendees from across the country came together to learn, connect, and imagine a better future—including a future where air travel is safe, accessible, and dignified for all wheelchair users. While progress is being made, many individuals and families in the SMA community

The Future of Accessible Air Travel and Current Challenges for the SMA Community at Cure SMA’s 2025 Annual Conference Read More »

Cure SMA Awards $140,000 Grant to Mandana Arbab, PhD, at Boston Children’s Hospital

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board then ranks the submitted proposals on both their scientific merit and relevance to Cure SMA’s research priorities. Funding is awarded to the highest ranked projects.

Cure SMA Awards $140,000 Grant to Mandana Arbab, PhD, at Boston Children’s Hospital Read More »

Cure SMA Awards $100,000 Grant to Yongchao Ma, PhD, at Ann & Robert H. Lurie Children’s Hospital of Chicago

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board then ranks the submitted proposals on both their scientific merit and relevance to Cure SMA’s research priorities. Funding is awarded to the highest ranked projects.

Cure SMA Awards $100,000 Grant to Yongchao Ma, PhD, at Ann & Robert H. Lurie Children’s Hospital of Chicago Read More »

Cure SMA Awards $150,000 Grant to Umrao Monani, PhD, at Columbia University Irving Medical Center

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board then ranks the submitted proposals on both their scientific merit and relevance to Cure SMA’s research priorities. Funding is awarded to the highest ranked projects.

Cure SMA Awards $150,000 Grant to Umrao Monani, PhD, at Columbia University Irving Medical Center Read More »

Biogen Announces Advancement of Investigational SMA Drug Salanersen to Registrational Trials Based on Positive Phase 1 Results

“To see a child dosed with gene therapy at age one and still unable to sit at age five then gain that ability within three months of starting salanersen is unexpected and encouraging,” – Dr. Valeria Sansone, principal investigator of the Phase 1 trial   Biogen Inc. announced today that it will advance its investigational

Biogen Announces Advancement of Investigational SMA Drug Salanersen to Registrational Trials Based on Positive Phase 1 Results Read More »

Cure SMA Awards $149,202 Grant to Rico Schieweck, PhD, at the Luxembourg Center for Systems Biomedicine (LCSB)

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board then ranks the submitted proposals on both their scientific merit and relevance to Cure SMA’s research priorities. Funding is awarded to the highest ranked projects.

Cure SMA Awards $149,202 Grant to Rico Schieweck, PhD, at the Luxembourg Center for Systems Biomedicine (LCSB) Read More »

Cure SMA Awards $50,000 Grant to Tianyuan Shi, PhD, at the University of Hong Kong

Each year, Cure SMA invites scientists from around the world to submit funding proposals for basic research projects that address specific unanswered questions in SMA biology. Our Scientific Advisory Board then ranks the submitted proposals on both their scientific merit and relevance to Cure SMA’s research priorities. Funding is awarded to the highest ranked projects.

Cure SMA Awards $50,000 Grant to Tianyuan Shi, PhD, at the University of Hong Kong Read More »

Scroll to Top